News from viropharma incorporated A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 11, 2013, 02:00 ET

Shire to Acquire ViroPharma in Strategic Move to Strengthen Rare Disease Portfolio; Will Augment Already Strong Growth Prospects

Shire plc (LSE: SHP, NASDAQ: SHPG) and ViroPharma Incorporated (NASDAQ: VPHM) today announce that their Boards of Directors have unanimously...

Nov 06, 2013, 14:29 ET

ViroPharma Announces Upcoming Data Presentations at the 2013 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting

 ViroPharma Incorporated (NASDAQ: VPHM) today announced it will present data relating to the quality of life in patients with Hereditary...

Oct 31, 2013, 07:30 ET

ViroPharma Incorporated Reports Third Quarter 2013 Financial Results

ViroPharma Incorporated (Nasdaq: VPHM) reported today its financial results for the third quarter ended September 30, 2013.  Net sales were...

Oct 28, 2013, 12:00 ET

ViroPharma To Release 2013 Third Quarter Financial Results On October 31, 2013

ViroPharma Incorporated's (Nasdaq: VPHM) third quarter financial results for 2013 are expected to be released on Thursday, October 31, 2013 before...

Sep 27, 2013, 11:00 ET

ViroPharma To Participate In The Leerink Swann Rare Disease Conference

 ViroPharma Incorporated (Nasdaq: VPHM) today announced that the company will present at the Leerink Swann Rare Disease conference at 1:40 PM...

Sep 16, 2013, 02:00 ET

ViroPharmas Buccolam® (midazolam munhålelösning) har godkänts för att ingå i läkemedelsförmånerna

ViroPharma Incorporated (Nasdaq: VPHM) meddelade idag att Buccolam® (midazolam munhålelösning) har godkänts av Tandvårds-...

Sep 09, 2013, 15:00 ET

ViroPharma To Participate In The Stifel Nicolaus 2013 Healthcare Conference

ViroPharma Incorporated (Nasdaq: VPHM) today announced that the company will present at the Stifel Nicolaus 2013 Healthcare Conference at 8:35 AM...

Aug 01, 2013, 07:30 ET

ViroPharma Announces Second Quarter 2013 Financial Results

 VIROPHARMA INCORPORATED (Nasdaq: VPHM) today announced financial results for the second quarter of 2013. Net sales were $104 million for the...

Aug 01, 2013, 07:00 ET

ViroPharma Provides Update On Phase 2 Clinical Evaluation Of Subcutaneous Cinryze® (C1 Esterase Inhibitor [Human]) With Recombinant Human Hyaluronidase (rHuPH20)

 ViroPharma Incorporated (NASDAQ: VPHM) today announced that following discussion with the Center for Biologics...

Jul 25, 2013, 13:00 ET

ViroPharma To Release 2013 Second Quarter Financial Results On August 1, 2013

ViroPharma Incorporated's (Nasdaq: VPHM) second quarter financial results for 2013 are expected to be released on Thursday, August 1, 2013 before...

Jul 01, 2013, 13:00 ET

ViroPharma to Participate in the JMP Securities 2013 Healthcare Conference

 ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present...

Jun 27, 2013, 08:00 ET

ViroPharma Provides Update From Ongoing Phase 2 Studies of Maribavir for Treatment of Cytomegalovirus (CMV) Infections

 ViroPharma Incorporated (Nasdaq: VPHM) today announced updated data from the two ongoing, Phase 2 dose ranging studies investigating maribavir...

Jun 19, 2013, 03:00 ET

ViroPharmas Buccolam® (midazolam, munnvann, oppløsning) er nå godkjent og tilgjengelig i Norge for akutt behandling av anfall hos barn og ungdom

 ViroPharma Incorporated (Nasdaq: VPHM) melder i dag at Buccolam® (midazolam, munnvann, oppløsning) er godkjent for...

Jun 11, 2013, 03:30 ET

ViroPharma Receives Orphan Drug Designation For Maribavir In Europe

ViroPharma Incorporated (Nasdaq: VPHM) today announced that the European Commission has granted orphan drug designation for maribavir for treatment...

May 31, 2013, 14:00 ET

ViroPharma To Participate In Several June Healthcare Investor Conferences

 ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present...

May 28, 2013, 07:30 ET
May 16, 2013, 01:00 ET

ViroPharma er stolt over at bakke op om HAE-dag :-) 2013 og vi hjælper HAE-patienter med at fylde verden med smil

HAE-dagen :-) finder sted 16. maj 2013 og har til formål at øge kendskabet til hereditært angioødem (HAE) Send et smil til...

May 16, 2013, 01:00 ET

ViroPharma unterstützt den HAE Day :-) 2013 und bringt zusammen mit HAEi Menschen weltweit zum lächeln

Der HAE Day :-) am 16. Mai 2013 soll das öffentliche Bewusstsein für das hereditäre Angioödem (HAE) schärfen Schicken...

May 09, 2013, 17:00 ET

ViroPharma To Participate In Two May Healthcare Investor Conferences

ViroPharma Incorporated (Nasdaq: VPHM) today announced that Robert Doody, director of investor relations, will present at the 2013 Bank of America...